| EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis A Verma, A Singh, MP Singh, MA Nengroo, KK Saini, SR Satrusal, ... Nature Communications 13 (1), 7344, 2022 | 39 | 2022 |
| Extraction, fractionation and re-fractionation of Artemisia nilagirica for anticancer activity and HPLC-ESI-QTOF-MS/MS determination N Sahu, S Meena, V Shukla, P Chaturvedi, B Kumar, D Datta, KR Arya Journal of Ethnopharmacology 213, 72-80, 2018 | 31 | 2018 |
| Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells AK Singh, A Verma, A Singh, RK Arya, S Maheshwari, P Chaturvedi, ... Epigenetics 16 (2), 144-161, 2021 | 23 | 2021 |
| CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5 MA Nengroo, S Maheshwari, A Singh, A Verma, RK Arya, P Chaturvedi, ... Cell Death & Disease 12 (5), 464, 2021 | 21 | 2021 |
| Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer KK Saini, P Chaturvedi, A Sinha, MP Singh, MA Khan, A Verma, ... Redox Biology 65, 102833, 2023 | 12 | 2023 |
| New Spisulosine Derivative promotes robust autophagic response to cancer cells A Ganesher, P Chaturvedi, R Sahai, S Meena, K Mitra, D Datta, G Panda European Journal of Medicinal Chemistry 188, 112011, 2020 | 9 | 2020 |
| One pot synthesis of N-monoalkylated plinabulin derivatives via multicomponent protocol and their application as anticancer agents A Ganesher, P Chaturvedi, BB Karkara, I Chatterjee, D Datta, G Panda Journal of Molecular Structure 1229, 129830, 2021 | 5 | 2021 |
| Design, synthesis and biological evaluation of oxime lacking Psammaplin inspired chemical libraries as anti-cancer agents K Ali, P Chaturvedi, S Meena, D Datta, G Panda Journal of Molecular Structure 1225, 129173, 2021 | 4 | 2021 |
| PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of system xc - (SLC7A11) KK Saini, P Chaturvedi, A Verma, MA Nengroo, A Sinha, A Singh, ... Cancer Research 82 (12_Supplement), 6249-6249, 2022 | 2 | 2022 |
| Epigenetic modulator EZH2 governs CSC properties and alters metastatic cascade A Verma, A Singh, AK Singh, P Chaturvedi, MA Nengroo, D Datta Cancer Medicine 7, 30-30, 2018 | 2 | 2018 |
| Selective ezh2 functional activation alters the metastatic landscape of triple negative breast cancer A Verma, A Singh, AK Singh, P Chaturvedi, MA Nengroo, K Saini, ... Cancer Research 80 (16_Supplement), 3837-3837, 2020 | 1 | 2020 |
| PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of SLC7A11 (System Xc-) KK Saini, P Chaturvedi, A Sinha, MP Singh, MA Khan, A Verma, ... bioRxiv, 2023.03. 28.534659, 2023 | | 2023 |
| CXCR4 intracellular protein regulates chemotherapy resistance by modulating the expression of death receptor 5 MA Nengroo, S Maheshwari, A Singh, AK Singh, P Chaturvedi, A Verma, ... Cancer Research 80 (16_Supplement), 6325-6325, 2020 | | 2020 |
| CXCR4 intracellular protein regulates drug resistance and tumorigenic potential via modulating the expression of Death Receptor 5 MA Nengroo, S Maheshwari, A Singh, AK Singh, RK Arya, P Chaturvedi, ... bioRxiv, 843995, 2019 | | 2019 |
| Tumor Microenvironment and Cancer Stem Cells: Therapeutic Potential of Epigenetic Inhibitors to Target Cancer Stem Cells AK Singh, P Chaturvedi, D Datta Rediscovering Cancer: From Mechanism to Therapy, 585-602, 2018 | | 2018 |
| Chemokine receptor CXCR4 but not CXCR7 promotes drug resistance in cancer via death receptor downregulation S Maheshwari, MA Nengroo, A Singh, P Chaturvedi, A Verma, D Datta CANCER MEDICINE 7, 40-40, 2018 | | 2018 |
